Roselie E. Achten
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Current treatment landscape of atopic dermatitis focusing on real-world evidence of dupilumab treatment.
Journal: Expert opinion on biological therapy
Published: December 01, 2025
Ocular surface disease in pediatric patients with moderate-to-severe atopic dermatitis.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: October 23, 2024
Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: August 24, 2023
Hidden in plain sight: complex tachycardias in a young thalassaemia patient.
Journal: Acta cardiologica
Published: June 15, 2023
Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile.
Journal: Ocular immunology and inflammation
Published: February 28, 2023
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: January 11, 2023
Dupilumab-associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis.
Journal: Allergy
Published: January 10, 2023
High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease.
Journal: Clinical and translational allergy
Published: December 01, 2022
Association of Serum Dupilumab Levels at 16 Weeks With Treatment Response and Adverse Effects in Patients With Atopic Dermatitis: A Prospective Clinical Cohort Study From the BioDay Registry.
Journal: JAMA dermatology
Published: November 02, 2022
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: October 17, 2022
Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis.
Journal: Acta dermato-venereologica
Published: October 06, 2022
Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.
Journal: Acta dermato-venereologica
Published: January 31, 2022
Last Updated: 09/26/2026